Startups
SenzaGen develops, performs and sells state-of-the-art non-animal tests for assessing a substance’s allergenicity. The GARD®test method combines genomic data from human cells with machine learning for a unique capability to assess whether a chemical could cause allergic reactions on the skin or in the respiratory tract. With excellent predictivity, GARD®meets needs in several industries and helps companies develop, produce and deliver safer and more sustainable products.
Overview
Location
United States, North Carolina, Chapel Hill
Employees
11-50
Founded date
2010
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 4, 2024 | SenzaGen will present at the BioStock Life Science Summit, November 21 | SenzaGen will present at the BioStock Life Science Summit, November 21 Mon, Nov 04, 2024 11:00 CET Report this content The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CEO Peter Nählstedt wi... |
| Dec 1, 2021 | SenzaGen receives SEK 1m follow-on order for GARD®skin Dose-Response from one of the world's largest cosmetics companies | SenzaGen secured another project to test ingredients in cosmetics products from one of the largest cosmetics companies in the world. The new order is valued at around SEK 1 million and is for the Company’s unique in vitro test, GARD®skin Do... |
| Oct 29, 2021 | SenzaGen completes a directed share issue of SEK 30 million | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE ... |
| May 11, 2021 | Skin Sensitizing Potency Assessment: Filling in Data Gaps, Upcoming Webinar Hosted by Xtalks | The GARD assays offer all-around in vitro skin sensitization testing alternatives, from binary hazard identification to quantitative potency information on a continuous scale. TORONTO (PRWEB) May 11, 2021 In this webinar you will learn how ... |
Reviews 0
FAQ about SenzaGen
When was SenzaGen founded?
SenzaGen was founded in 2010.
What has the press written about SenzaGen?
Parsers VC has collected 5 articles mentioning SenzaGen, among them “SenzaGen will present at the BioStock Life Science Summit, November 21” (Nov 4, 2024) and “SenzaGen receives SEK 1m follow-on order for GARD®skin Dose-Response from one of the world's largest cosmetics companies” (Dec 1, 2021).
Is SenzaGen still active?
Yes, SenzaGen is active; its latest activity on Parsers VC dates from Oct 14, 2025.